World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
25050
World Ranking
16598
National Ranking
8336

Overview

Martha Skinner is affiliated with Boston University in the United States. Their research contributions include publications in recognized academic venues, with a focus visible through their recent work.

Recent papers by Martha Skinner include:

  • In memoriam: Lawreen Connors, Ph.D. (2024), published in Amyloid

They have a collaborative relationship with co-author Vaishali Sanchorawala, with whom they have worked on at least one publication.

Martha Skinner's work appears in the following publication venue:

  • Amyloid

Best Publications

  • A Report of Three Cases

    William D. Travis;Robert Castile;Gordon Vawter;Harry Shwachman

  • The Systemic Amyloidoses

    Rodney H. Falk;Raymond L. Comenzo;Martha Skinner

  • Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial

    John L. Berk;Ole B. Suhr;Laura Obici;Yoshiki Sekijima

  • High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

    Martha Skinner;Vaishali Sanchorawala;David C Seldin;Laura M Dember

  • The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.

    S W Dubrey;K Cha;J Anderson;B Chamarthi

  • Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

    Daniel A. Brenner;Mohit Jain;David R. Pimentel;Bo Wang

  • Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only

    Martha Skinner;Jennifer J. Anderson;Robert Simms;Rodney Falk

  • Senile Systemic Amyloidosis Presenting With Heart Failure A Comparison With Light Chain-Associated Amyloidosis

    Belinda Ng;Lawreen H. Connors;Ravin Davidoff;Martha Skinner

  • Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

    R. L. Comenzo;D. Reece;G. Palladini;D. Seldin

  • Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis : Survival and responses in 25 patients

    Raymond L. Comenzo;Evan Vosburgh;Rodney H. Falk;Vaishali Sanchorawala

  • Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts

    Ronglih Liao;Mohit Jain;Paige Teller;Lawreen H. Connors

  • Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

    Maria Teresa Cibeira;Vaishali Sanchorawala;Vaishali Sanchorawala;David C. Seldin;David C. Seldin;Karen Quillen;Karen Quillen

  • Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).

    Frederick L. Ruberg;Mathew S. Maurer;Daniel P. Judge;Steven Zeldenrust

  • Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study.

    Lawreen H. Connors;Flora Sam;Martha Skinner;Francesco Salinaro

  • Eprodisate for the treatment of renal disease in AA amyloidosis.

    Laura M. Dember;Philip N. Hawkins;Bouke P.C. Hazenberg;Peter D. Gorevic

  • Bleeding manifestations in 100 patients with amyloidosis.

    Robert A. Yood;Martha Skinner;Alan Rubinow;Lilia Talarico

  • Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis.

    Rodney H. Falk;Jonathan F. Plehn;Thomas Deering;Edgar C. Schick

  • Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy.

    Elie B. Choufani;Vaishali Sanchorawala;Vaishali Sanchorawala;Timothy Ernst;Timothy Ernst;Karen Quillen;Karen Quillen

  • Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

    S. W. Dubrey;K. Cha;M. Skinner;M. LaValley

  • Digoxin sensitivity in amyloid cardiomyopathy.

    A Rubinow;M Skinner;A S Cohen

Frequent Co-Authors

Alan S. Cohen
Alan S. Cohen Boston University
David C. Seldin
David C. Seldin Boston University
Rodney H. Falk
Rodney H. Falk Brigham and Women's Hospital
Catherine E. Costello
Catherine E. Costello Boston University
Jean D. Sipe
Jean D. Sipe Boston University
Merrill D. Benson
Merrill D. Benson Indiana University
Jennifer J. Anderson
Jennifer J. Anderson Boston University
Giampaolo Merlini
Giampaolo Merlini University of Pavia
Robert A. Kyle
Robert A. Kyle Mayo Clinic
Morie A. Gertz
Morie A. Gertz Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Medicine opens doors to a variety of healthcare careers. For those interested in healthcare leadership, consider the cheapest master's in healthcare administration. This degree is ideal for students aiming for management roles in hospitals and clinics.

Nurses looking to advance their expertise and increase their earning potential should explore cheap dnp online programs. Doctor of Nursing Practice (DNP) degrees can be more flexible and accessible than ever before thanks to online offerings.

For those fascinated by medication and patient care, an online pharmacy degree is a strong choice. These programs combine clinical knowledge with skills in patient counseling and pharmacological science.

Finally, if you are interested in the intersection of technology and healthcare, a bachelor of health information management online can prepare you for careers involving medical records, data analysis, and healthcare IT.

Best Scientists Citing Martha Skinner

Trending Scientists

Recently Published Articles